These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23446952)

  • 1. Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.
    Bartold PM; du Bois AH; Gannon S; Haynes DR; Hirsch RS
    Inflammopharmacology; 2013 Aug; 21(4):321-38. PubMed ID: 23446952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin: a new concept in adjuvant treatment of periodontitis.
    Muniz FW; de Oliveira CC; de Sousa Carvalho R; Moreira MM; de Moraes ME; Martins RS
    Eur J Pharmacol; 2013 Apr; 705(1-3):135-9. PubMed ID: 23499686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin in the treatment of periodontal disease. Effect on microbial flora.
    Sefton AM; Maskell JP; Beighton D; Whiley A; Shain H; Foyle D; Smith SR; Smales FC; Williams JD
    J Clin Periodontol; 1996 Nov; 23(11):998-1003. PubMed ID: 8951627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prospects for using the new macrolide antibiotic azithromycin (Sumamed) in the combined treatment of periodontitis].
    Filatova NA; Kuznetsov EA; Dmitrieva LA; Tsarev VN; Kalinin AI
    Stomatologiia (Mosk); 1995; 74(1):12-5. PubMed ID: 7770869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin.
    Higgins TJ
    Aust Dent J; 2010 Dec; 55(4):479; author reply 479-81. PubMed ID: 21133950
    [No Abstract]   [Full Text] [Related]  

  • 6. Subantibiotic dose of azithromycin attenuates alveolar bone destruction and improves trabecular microarchitectures in a rat model of experimental periodontitis: A study using micro-computed tomography.
    Park HS; Lee YS; Choi EY; Choi JI; Choi IS; Kim SJ
    Int Immunopharmacol; 2017 Jun; 47():212-217. PubMed ID: 28432937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A trial of the use of rulid, sumamed and makropen in the combined treatment of generalized periodontitis at a stage of exacerbation].
    Tsarev VN; Dmitrieva LA; Filatova NA; Romanov AE; Chekhova NO
    Stomatologiia (Mosk); 1997; 76(5):4-8. PubMed ID: 9411932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.
    Venditto VJ; Feola DJ
    Adv Drug Deliv Rev; 2022 May; 184():114252. PubMed ID: 35367307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides and changes in the oral flora.
    Sefton AM
    Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S23-9; discussion S31-2. PubMed ID: 10204636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The newer macrolides: azithromycin and clarithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative effect of azithromycin on periodontitis with different levels of gingival inflammation: three case reports.
    Fujise O; Miura M; Hamachi T; Aida Y; Nishimura F
    Aust Dent J; 2014 Jun; 59(2):245-51. PubMed ID: 24861402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin in periodontal treatment: more than an antibiotic.
    Hirsch R; Deng H; Laohachai MN
    J Periodontal Res; 2012 Apr; 47(2):137-48. PubMed ID: 22050485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
    J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with macrolides in patients with cystic fibrosis.
    Gaylor AS; Reilly JC
    Pharmacotherapy; 2002 Feb; 22(2):227-39. PubMed ID: 11837560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2'-Dehydroxy-5″-Epi-Azithromycin.
    Kragol G; Steadman VA; Marušić Ištuk Z; Čikoš A; Bosnar M; Jelić D; Ergović G; Trzun M; Bošnjak B; Bokulić A; Padovan J; Glojnarić I; Eraković Haber V
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development.
    Kricker JA; Page CP; Gardarsson FR; Baldursson O; Gudjonsson T; Parnham MJ
    Pharmacol Rev; 2021 Oct; 73(4):233-262. PubMed ID: 34716226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, in vitro and in vivo evaluation of novel injectable smart gels of azithromycin for chronic periodontitis.
    Venkatesh MP; Kumar TM; Avinash BS; Kumar GS
    Curr Drug Deliv; 2013 Apr; 10(2):188-97. PubMed ID: 23003342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides.
    Tevyashova AN; Bychkova EN; Korolev AM; Isakova EB; Mirchink EP; Osterman IA; Erdei R; Szücs Z; Batta G
    Bioorg Med Chem Lett; 2019 Jan; 29(2):276-280. PubMed ID: 30473176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases.
    Blandizzi C; Malizia T; Lupetti A; Pesce D; Gabriele M; Giuca MR; Campa M; Del Tacca M; Senesi S
    J Periodontol; 1999 Sep; 70(9):960-6. PubMed ID: 10505797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.